This inventor holds 3 USPTO granted patents. Top assignee: Roche Diagnostics Gmbh. Active years: 2001-2004.
Location History:
- Weilheim, DE (2001)
- Peissenberg, DE (2004)
Company Filing History:
Years Active: 2001-2004
Title: Ralph Weisheit: Innovator in Alkaline Phosphatase Determination
Introduction
Ralph Weisheit is a notable inventor based in Peissenberg, Germany. He has made significant contributions to the field of biochemical analysis, particularly in the determination of alkaline phosphatase. With a total of 3 patents to his name, Weisheit's work has advanced the methods used in clinical diagnostics.
Latest Patents
Weisheit's latest patents focus on innovative methods for determining alkaline phosphatase levels in samples. One of his key inventions is a method that utilizes optical measurement to determine alkaline phosphatase while eliminating interference from free hemoglobin or blood substitutes through specific wavelength combinations. Another patent details a method that employs a main measurement wavelength of 450±10 nm in conjunction with a rate blank procedure to effectively eliminate hemoglobin interference. These inventions are crucial for improving the accuracy of biochemical assays.
Career Highlights
Ralph Weisheit is currently associated with Roche Diagnostics GmbH, a leading company in the field of medical diagnostics. His work at Roche has allowed him to develop and refine methods that enhance the reliability of diagnostic tests. His contributions have been instrumental in advancing the capabilities of clinical laboratories.
Collaborations
Throughout his career, Weisheit has collaborated with esteemed colleagues such as Wolfgang Treiber and Lieselotte Schellong. These partnerships have fostered an environment of innovation and have led to the successful development of new diagnostic methods.
Conclusion
Ralph Weisheit's contributions to the field of alkaline phosphatase determination exemplify the impact of innovative thinking in medical diagnostics. His patents not only enhance the accuracy of biochemical measurements but also reflect his commitment to advancing healthcare technology.